Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

SANA Sana Biotechnology Inc

7,56

0,06 (0,80%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sana Biotechnology (NASDAQ:SANA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Sana Biotechnology Charts.

Sana Biotechnology (NASDAQ:SANA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Sana Biotechnology Charts.

News Sana Biotechnology Inc

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 8 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
Mittwoch 8 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Sana Biotechnology to Present at May and June 2024 Investor Conferences
Montag 6 Mai 2024 (5 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Donnerstag 29 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
Mittwoch 28 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
Dienstag 13 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Sana Biotechnology Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen